LivaNova Plc (LIVN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1241229,
    "name": "LivaNova Plc",
    "stock_name": "LivaNova Plc",
    "full_name": "LivaNova Plc",
    "name_url": "stocks-analysis/livanova-plc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "63.90",
    "chg": 0.22,
    "chgp": "0.35%",
    "dir": 1,
    "prev_price": "63.68",
    "mcapval": "3,214.11",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "GB00BYMT0J19",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "381.66 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/livanova-plc-1241229-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "LivaNova Plc Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/livanova-plcs-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-stock-price-increase-3649036",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LivaNovaPlc_technicaldot_3649036.png",
        "date": "2025-10-27 15:48:52",
        "description": "LivaNova Plc, a small-cap in the Pharmaceuticals and Biotechnology sector, has seen its stock price rise slightly to $54.89. The company has experienced significant volatility over the past year, with a 52-week high of $58.91 and a low of $32.48, while outperforming the S&P 500 year-to-date."
      },
      {
        "title": "LivaNova Plc Experiences Revision in Stock Evaluation Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/livanova-plcs-technical-trend-changes-from-bullish-to-mildly-bullish-amid-stock-price-increase-3579863",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/LivaNovaPlc_technicaldot_3579863.png",
        "date": "2025-09-29 16:04:33",
        "description": "LivaNova Plc, a small-cap in the Pharmaceuticals & Biotechnology sector, has seen its stock price rise slightly to $53.44. Over the past year, it has returned 2.16%, contrasting with the S&P 500's 15.64%. The stock shows mixed technical indicators, reflecting volatility and resilience in a fluctuating market."
      },
      {
        "title": "Is LivaNova Plc technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-livanova-plc-technically-bullish-or-bearish-3547565",
        "imagepath": "",
        "date": "2025-09-20 19:58:17",
        "description": "As of 13 August 2025, the technical trend for LivaNova Plc has changed from mildly bullish to bullish. Key indicators supporting this bullish stance include a bullish MACD on the weekly timeframe, bullish moving averages on the daily timeframe, and a bullish KST on the weekly. While the monthly MACD is mildly bullish, the overall sentiment remains positive. The stock has underperformed the S&P 500 over the 1-year, 3-year, and 5-year periods, but has outperformed in the year-to-date comparison...."
      },
      {
        "title": "Is LivaNova Plc overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-livanova-plc-overvalued-or-undervalued-3543899",
        "imagepath": "",
        "date": "2025-09-20 18:31:59",
        "description": "As of 7 May 2025, LivaNova Plc's valuation grade has moved from attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued, particularly given its negative P/E ratio and poor returns on capital, with a Price to Book Value of 2.45 and an EV to Sales ratio of 1.90. In comparison, peers such as Globus Medical, Inc. have a much more favorable P/E ratio of 18.37, while Sanmina Corp. boasts a significantly higher P/E of 39.80, highlighting LivaNova's relative weakness in valuation metrics.\n\nAdditionally, LivaNova's recent stock performance has lagged behind the S&P 500, with a YTD return of 20.73% compared to the index's 12.22%, but over the longer term, its 5-year return of 25.05% still falls short of the S&P 500's 96.61%. This underperformance, combined with the company's negative financial ratios, reinforces the conclusion that LivaNova is ove..."
      }
    ],
    "total": 9,
    "sid": "1241229",
    "stock_news_url": "https://www.marketsmojo.com/news/livanova-plc-1241229"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

LivaNova Plc Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-27 15:48:52

LivaNova Plc, a small-cap in the Pharmaceuticals and Biotechnology sector, has seen its stock price rise slightly to $54.89. The company has experienced significant volatility over the past year, with a 52-week high of $58.91 and a low of $32.48, while outperforming the S&P 500 year-to-date.

LivaNova Plc Experiences Revision in Stock Evaluation Amid Mixed Market Signals

2025-09-29 16:04:33

LivaNova Plc, a small-cap in the Pharmaceuticals & Biotechnology sector, has seen its stock price rise slightly to $53.44. Over the past year, it has returned 2.16%, contrasting with the S&P 500's 15.64%. The stock shows mixed technical indicators, reflecting volatility and resilience in a fluctuating market.

Is LivaNova Plc technically bullish or bearish?

2025-09-20 19:58:17

As of 13 August 2025, the technical trend for LivaNova Plc has changed from mildly bullish to bullish. Key indicators supporting this bullish stance include a bullish MACD on the weekly timeframe, bullish moving averages on the daily timeframe, and a bullish KST on the weekly. While the monthly MACD is mildly bullish, the overall sentiment remains positive. The stock has underperformed the S&P 500 over the 1-year, 3-year, and 5-year periods, but has outperformed in the year-to-date comparison....

Is LivaNova Plc overvalued or undervalued?

2025-09-20 18:31:59

As of 7 May 2025, LivaNova Plc's valuation grade has moved from attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued, particularly given its negative P/E ratio and poor returns on capital, with a Price to Book Value of 2.45 and an EV to Sales ratio of 1.90. In comparison, peers such as Globus Medical, Inc. have a much more favorable P/E ratio of 18.37, while Sanmina Corp. boasts a significantly higher P/E of 39.80, highlighting LivaNova's relative weakness in valuation metrics. Additionally, LivaNova's recent stock performance has lagged behind the S&P 500, with a YTD return of 20.73% compared to the index's 12.22%, but over the longer term, its 5-year return of 25.05% still falls short of the S&P 500's 96.61%. This underperformance, combined with the company's negative financial ratios, reinforces the conclusion that LivaNova is ove...

View All News